1.
Rada FH. Adequacy of Olmesartan monotherapy versus cotherapy in patients with essential hypertension. ijrps [Internet]. 2020Apr.6 [cited 2020Oct.30];11(2):1649-54. Available from: https://pharmascope.org/ijrps/article/view/2047